Compared to regular human insulin, five faster-acting insulin analogues may offer similar benefits in controlling blood glucose levels. Compared to regular human insulin, some of them (ultra-rapid ...

A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to ...

When I receive questions about pre-diabetes and Type 2 diabetes, it’s clear there is considerable confusion surrounding the underlying cause, which is insulin resistance, so let's start with some ...

Type 1 diabetes (T1D) is commonly diagnosed in childhood and the teen years. It’s a lifelong condition that requires treatment. Type 1 diabetes (T1D) is an autoimmune disease that occurs when the ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...

Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly common autoimmune disease. Diabetes, both type 1 and ...

Diabetes develops when the body fails to manage its blood glucose levels. One form of diabetes causes the body to not produce insulin at all. Called Type 1 diabetes, or T1D, this autoimmune disease ...

The immunotherpay can give children and adults three extra years before they need to use insulin.

Type 1 diabetes is characterized by immune-associated destruction of insulin producing pancreatic beta cells resulting in a lifelong reliance on insulin replacement. However, cardiovascular disease ...

Teplizumab, also known as Tzield and made by Sanofi, is approved for children aged 8 and over and adults who have early-stage ...

Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly common autoimmune disease. Diabetes, both type 1 and ...